HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chantal Mathieu Selected Research

Glucagon-Like Peptide 1 (GLP 1)

3/2024CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.
10/2023Incretins beyond type 2 diabetes.
1/2023CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.
10/2022New strategies to improve clinical outcomes for diabetic kidney disease.
1/20202019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
1/20202019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
12/2018Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
12/2018Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
10/2012GLP1 and cancer: friend or foe?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chantal Mathieu Research Topics

Disease

157Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2024 - 08/2002
65Type 2 Diabetes Mellitus (MODY)
03/2024 - 12/2004
42Hypoglycemia (Reactive Hypoglycemia)
03/2024 - 11/2006
27Neoplasms (Cancer)
07/2022 - 12/2002
27Inflammation (Inflammations)
01/2020 - 01/2002
26Autoimmune Diseases (Autoimmune Disease)
02/2024 - 04/2002
20Body Weight (Weight, Body)
04/2023 - 06/2005
19Vitamin D Deficiency
02/2019 - 01/2008
17Hyperglycemia
07/2022 - 02/2006
15Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
03/2024 - 03/2016
14Weight Loss (Weight Reduction)
01/2024 - 12/2003
14Insulin Resistance
01/2024 - 09/2004
13Cardiovascular Diseases (Cardiovascular Disease)
03/2024 - 04/2009
13Gestational Diabetes (Gestational Diabetes Mellitus)
01/2023 - 03/2003
13Infections
03/2022 - 06/2007
12Chronic Renal Insufficiency
03/2024 - 09/2010
11Heart Failure
03/2024 - 03/2017
9Obesity
03/2024 - 01/2012
9Chronic Obstructive Pulmonary Disease (COPD)
03/2022 - 04/2009
8Disease Progression
06/2023 - 08/2006
8Glucose Intolerance
01/2022 - 01/2008
7Gestational Weight Gain
05/2023 - 01/2016
6Weight Gain
01/2021 - 09/2009
5Diabetes Mellitus
11/2023 - 08/2005
5Diabetes Complications
01/2023 - 04/2002
5Ketosis
12/2021 - 06/2002
5Hypoxia (Hypoxemia)
04/2018 - 02/2015
4Immune System Diseases (Immune Disorders)
11/2023 - 01/2003
4Albuminuria
10/2022 - 07/2013
4Endometriosis
09/2011 - 06/2006
4Asthma (Bronchial Asthma)
08/2008 - 01/2003
3Pneumonia (Pneumonitis)
03/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

102Insulin (Novolin)FDA Link
04/2024 - 06/2002
91Glucose (Dextrose)FDA LinkGeneric
03/2024 - 12/2002
51Vitamin DFDA LinkGeneric
03/2022 - 01/2003
28CytokinesIBA
01/2024 - 02/2003
221,25-dihydroxyvitamin DIBA
03/2020 - 04/2002
19Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2002
16dapagliflozinIBA
03/2024 - 11/2015
15AutoantibodiesIBA
03/2024 - 10/2009
15Biomarkers (Surrogate Marker)IBA
11/2023 - 03/2008
15Metformin (Glucophage)FDA LinkGeneric
01/2023 - 01/2008
14AntigensIBA
02/2024 - 02/2003
13Calcitriol Receptors (Calcitriol Receptor)IBA
01/2017 - 01/2003
11Sodium-Glucose Transporter 2 InhibitorsIBA
03/2024 - 03/2017
10Sodium-Glucose Transport ProteinsIBA
07/2023 - 03/2016
9C-PeptideIBA
03/2024 - 06/2002
9Glucagon-Like Peptide-1 Receptor AgonistsIBA
03/2024 - 05/2011
9Glucagon-Like Peptide 1 (GLP 1)IBA
03/2024 - 10/2012
9Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
03/2024 - 04/2012
9AutoantigensIBA
11/2018 - 02/2003
8Insulin Glargine (Lantus)FDA Link
02/2024 - 03/2011
8SodiumIBA
01/2023 - 11/2015
825-hydroxyvitamin DIBA
03/2020 - 04/2009
7Peptides (Polypeptides)IBA
02/2024 - 11/2003
7Blood Glucose (Blood Sugar)IBA
01/2021 - 04/2006
7hydroxide ionIBA
03/2020 - 02/2003
7Hypoglycemic Agents (Hypoglycemics)IBA
01/2020 - 10/2006
7Interleukin-6 (Interleukin 6)IBA
02/2019 - 06/2006
7Messenger RNA (mRNA)IBA
02/2019 - 01/2002
7Calcitriol (Calcijex)FDA LinkGeneric
02/2015 - 08/2002
6AntibodiesIBA
03/2024 - 11/2011
6InsulinsIBA
03/2024 - 12/2012
6Hormones (Hormone)IBA
01/2024 - 04/2002
6Insulin Aspart (NovoLog)FDA Link
11/2023 - 01/2017
6CalciumIBA
11/2016 - 01/2011
5insulin degludecIBA
03/2024 - 03/2011
5EnzymesIBA
01/2021 - 10/2008
5saxagliptinFDA Link
01/2019 - 11/2015
525-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA
01/2017 - 10/2008
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2015 - 06/2006
5AllergensIBA
08/2008 - 01/2002
4Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
12/2021 - 11/2006
4LiraglutideFDA Link
12/2021 - 10/2016
4LipidsIBA
01/2021 - 01/2008
4otelixizumabIBA
01/2021 - 06/2005
4VildagliptinIBA
01/2021 - 01/2008
4Tacrolimus (Prograf)FDA LinkGeneric
10/2020 - 11/2006
4SmokeIBA
01/2019 - 09/2015
4Exenatide (Byetta)FDA Link
12/2013 - 11/2012
3omega-Chloroacetophenone (Mace)IBA
03/2024 - 01/2020
3insulin icodecIBA
02/2024 - 10/2023
3Immunoglobulin G (IgG)IBA
11/2023 - 11/2005
3CreatinineIBA
10/2023 - 01/2020
3Interleukin-10 (Interleukin 10)IBA
10/2023 - 05/2012
3IncretinsIBA
10/2023 - 05/2011
3AlbuminsIBA
10/2023 - 01/2020
3Glucagon-Like Peptide-1 ReceptorIBA
01/2023 - 01/2020
3Cholecalciferol (Vitamin D3)FDA Link
03/2022 - 08/2002
3Endoplasmic Reticulum Chaperone BiPIBA
12/2021 - 02/2015

Therapy/Procedure

63Therapeutics
04/2024 - 12/2003
26Glycemic Control
11/2023 - 04/2006
12Injections
11/2023 - 01/2002
8Transplantation
10/2020 - 04/2002
6Islets of Langerhans Transplantation
01/2018 - 02/2006
5Bariatric Surgery
01/2024 - 01/2012
4Immunotherapy
01/2024 - 05/2011
4Cesarean Section (Caesarean Section)
08/2022 - 06/2019
3Immunomodulation
10/2023 - 10/2005
3Kidney Transplantation
01/2022 - 12/2002